Direct Answer
Sleep medicine billing covers two distinct service categories: diagnostic sleep testing (polysomnography and home sleep testing) and therapeutic PAP device management. Diagnostic testing codes depend on whether the study is performed in a facility (polysomnography 95782-95811) or in the home (HSAT codes 95800-95806), the number of parameters recorded, and whether the study includes titration. PAP device billing is managed by DME suppliers using HCPCS E-codes, with Medicare requiring compliance monitoring data before continuing to cover the device after the initial 90-day period.
Table of Contents
Polysomnography Codes 95782-95811
Polysomnography (PSG) is a facility-based sleep study that records multiple physiological parameters simultaneously: Pediatric PSG (under age 6): 95782 — polysomnography; younger than 6 years, sleep staging with 4 or more additional parameters of sleep, attended by a technologist; 95783 — younger than 6 years, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation; Adult/older child PSG: 95805 — multiple sleep latency or maintenance of wakefulness testing, recording, analysis and interpretation of physiological measurements of sleep during multiple trials to assess sleepiness; 95808 — polysomnography; any age, sleep staging with 1-3 additional parameters of sleep, attended by a technologist; 95810 — any age, sleep staging with 4 or more additional parameters of sleep, attended by a technologist; 95811 — any age, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist; Split-night PSG: a split-night study performs the diagnostic portion and titration in a single night; if the split-night protocol is used: bill 95811 if CPAP or BiPAP was initiated; bill 95810 if titration was not achieved (insufficient OSA documented in the first half); TC/PC billing for PSG: when the physician interprets the sleep study but the facility provides the technical component: the facility bills 95810 or 95811 with Modifier TC; the interpreting physician bills 95810 or 95811 with Modifier 26; Parameters required: sleep staging requires EEG, EOG, and chin EMG as the minimum sleep staging montage; "4 or more additional parameters" distinguishes 95810 from 95808; additional parameters include EEG channels, respiratory effort, airflow, oximetry, EKG, limb movement EMG, snoring, video recording, CO2 monitoring.
Home Sleep Apnea Testing 95800-95806
Home sleep apnea testing (HSAT) provides a less expensive alternative to facility PSG for uncomplicated suspected obstructive sleep apnea: HSAT codes: 95800 — sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory analysis (e.g., by airflow or peripheral arterial tone), and sleep time; 95801 — minimum of heart rate, oxygen saturation, and respiratory analysis; 95803 — actigraphy testing, unattended, simultaneous recording; minimum of movement, heart rate, and light exposure, review and interpretation by a physician; 95806 — sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory airflow, and respiratory effort; HSAT vs. PSG selection: Medicare NCD 240.4.1 governs HSAT coverage; HSAT is appropriate for patients with high pretest probability of moderate-to-severe OSA without significant comorbidities that would confound the diagnosis; HSAT should not be used for: suspected complex sleep apnea; significant comorbidities (moderate-to-severe pulmonary disease, neuromuscular disease, congestive heart failure); prior negative HSAT when clinical suspicion remains high; pediatric patients (PSG required); Results that warrant PSG after negative HSAT: if the HSAT result is negative and clinical suspicion for OSA remains, the next step is attended PSG; the clinical documentation must explain why in-lab PSG is needed after a negative HSAT to support prior authorization; Technical requirements for HSAT billing: the device must be capable of recording all required parameters; the physician must review and interpret the raw data (not just the device-generated AHI report); interpretation must be documented in a signed report; recording of acceptable quality must be confirmed before billing.
PAP Therapy and DME Billing
PAP device billing is performed by the DME supplier, not the ordering physician, but physicians must understand the billing framework to properly document orders and compliance: PAP device HCPCS codes: E0601 — continuous airway pressure (CPAP) device; E0470 — respiratory assist device, bi-level pressure capability, without backup rate feature; E0471 — respiratory assist device, bi-level pressure capability, with backup rate feature; A7030-A7039 — PAP device accessories and supplies (masks, headgear, tubing, humidifier, filters); Medicare PAP coverage criteria: Medicare coverage requires: face-to-face clinical evaluation documenting signs/symptoms of OSA; in-lab PSG or HSAT showing AHI/RDI ≥ 15, or AHI/RDI ≥ 5 with documented symptoms; CPAP device and 90-day trial period; PAP compliance requirement: after initial 90-day trial, Medicare requires compliance data showing the beneficiary used the CPAP device for more than 4 hours per night on at least 70% of nights during any consecutive 30-day period in the first 90 days; if compliance is not met, Medicare will not cover the device beyond the 90-day trial; the DME supplier must obtain compliance data from the device (data card or wireless download) and document it in the patient file; auto-adjusting CPAP (APAP): APAP uses HCPCS E0601 with code KU modifier for auto-adjusting; prior authorization for higher-pressure devices (BiPAP, ASV) requires documentation of CPAP failure; Physician role in PAP billing: the physician provides the written order, documents OSA diagnosis, and provides compliance management visits; the physician bills separately for E&M or sleep medicine management visits — not for the device itself.
MSLT, MWT, and Other Sleep Studies
Beyond OSA diagnosis, sleep medicine covers narcolepsy, hypersomnia, and other sleep disorders with distinct testing protocols: Multiple Sleep Latency Test (MSLT): 95805 — multiple sleep latency or maintenance of wakefulness testing; MSLT: used to diagnose narcolepsy and idiopathic hypersomnia; consists of 4-5 nap opportunities spaced 2 hours apart; mean sleep latency ≤ 8 minutes with 2 or more sleep-onset REM periods (SOREMPs) is diagnostic for narcolepsy; must be preceded by a full-night PSG (typically 95810) on the night before; bill 95810 for the preceding PSG and 95805 for the MSLT on the following day; Maintenance of Wakefulness Test (MWT): 95805 — same code as MSLT; the MWT measures ability to stay awake (used for driving and occupational safety assessments in patients with narcolepsy or sleep disorders); 4 trials of 40 minutes each in a darkened room; Actigraphy: 95803 — actigraphy testing; used for assessment of circadian rhythm disorders, insomnia, and treatment response monitoring; records movement and light over multiple days; interpretation requires clinical correlation; Oximetry studies: 94762 — noninvasive ear or pulse oximetry for oxygen saturation; multiple determinations (e.g., during exercise); used for screening or follow-up but not as a standalone OSA diagnostic test; REM sleep behavior disorder (RBD): diagnosed by PSG with video monitoring showing loss of REM sleep atonia with movement; 95810 with documentation of expanded EMG monitoring; Pediatric sleep disorders: children under 6 require in-lab PSG (95782-95783) — HSAT is not appropriate for pediatric patients; pediatric PSG requires a pediatric-trained technologist and age-appropriate equipment and protocols.
Sleep Medicine Denials and RCM
Sleep medicine billing denials primarily involve medical necessity documentation, HSAT vs. PSG selection, and PAP compliance requirements: Common sleep medicine denial patterns: HSAT ordered when PSG required: payers deny HSAT claims when the patient has comorbidities (CHF, COPD, complex sleep disorders) that contraindicate home testing; the clinical documentation must confirm the patient is appropriate for HSAT — no significant comorbidities, high pretest OSA probability, no prior HSAT failure; PSG not authorized: most commercial payers require prior authorization for in-lab PSG; the PA request must document: clinical symptoms of OSA (Epworth Sleepiness Scale score, witnessed apneas, snoring, daytime sleepiness); prior HSAT result if applicable; clinical indication for in-lab study; PAP compliance denial: Medicare denies continued PAP coverage when compliance data is not documented; the DME supplier must track compliance data collection and ensure the 90-day compliance check occurs before the device rental exceeds the covered period; Sleep medicine RCM best practices: PSG interpretation report standards: the sleep study interpretation report must include: total sleep time, sleep efficiency, sleep stage percentages, AHI, minimum oxygen saturation, arousal index, PLMI (periodic limb movement index), and clinical interpretation with diagnosis; the report must be signed and dated by the interpreting physician; generic auto-generated device reports alone are not sufficient; clinical notes for HSAT orders: document why HSAT is appropriate for this patient (symptoms, pretest probability, absence of disqualifying comorbidities); this prevents payer denials and supports audit defense; follow-up visit documentation: after PSG or HSAT, the sleep medicine visit to discuss results and prescribe treatment is billed as E&M (99212-99215); the visit note must document the test results, diagnosis, and treatment plan with prescription details.
FAQ
What are the Medicare coverage criteria for CPAP and how does PAP compliance monitoring work?
Medicare's CPAP coverage criteria (NCD 240.4) are specific and must be documented precisely to support DME billing: Initial coverage criteria: the beneficiary must have a face-to-face clinical evaluation by the treating physician prior to the sleep test; the sleep test (PSG or HSAT) must show: AHI or RDI ≥ 15 events per hour; or AHI or RDI ≥ 5 and ≤ 14 events per hour with documentation of excessive daytime sleepiness, impaired cognition, mood disorders, insomnia, hypertension, ischemic heart disease, or history of stroke; the clinical evaluation and sleep test results must be documented in the medical record; Initial 90-day trial: the DME supplier furnishes the CPAP device for an initial 90-day period; if compliance is not demonstrated, coverage terminates at 90 days; Compliance threshold: "compliance" = use of CPAP device for ≥ 4 hours per night on ≥ 70% of nights during a consecutive 30-day period within the first 90 days; the device's data card or wireless telemetry system (AirView, MyAir, etc.) provides usage data; the DME supplier obtains and documents the compliance data; Compliance visit: Medicare requires documentation that the treating physician saw the beneficiary at least once between the 31st and 90th day of CPAP therapy to assess: use of the device; therapeutic benefit; any side effects; the visit documentation must be in the medical record and available to the DME supplier if requested; After 90 days: if compliance is met and documented, coverage continues; the DME supplier bills monthly rental codes (HCPCS E0601 RR for rental) or switches to capped rental billing; if compliance is not met, the beneficiary must pay out of pocket for continued CPAP use; Physician documentation responsibility: the ordering physician must document the face-to-face evaluation, sign the CPAP order, and perform the compliance visit within the 31–90 day window; missing any of these documentation steps can cause the DME claim to be denied retroactively.
Can a sleep study be billed with both the technical component (facility) and professional component (physician interpretation) separately?
Yes — polysomnography is a global service that can be billed with split TC/PC billing, similar to radiology and other diagnostic testing: Global billing (physician owns the sleep lab): when the interpreting physician both owns/operates the sleep lab and personally interprets the study, the global PSG code (95810 or 95811) is billed without a modifier; global billing includes both the technical component (equipment, technologist, facility) and the professional component (interpretation); TC/PC split billing: when the physician interprets studies from a hospital-based or independent sleep lab that they do not own: the facility (hospital, freestanding sleep center) bills the technical component: 95810 TC or 95811 TC; the interpreting physician bills the professional component: 95810-26 or 95811-26; this is the typical model for hospital-employed or contracted sleep medicine physicians; Independent Diagnostic Testing Facility (IDTF): a physician-owned sleep lab operating as an IDTF bills global codes; IDTFs must comply with Medicare IDTF standards including: minimum equipment standards; interpreting physician qualifications (board certification in sleep medicine); supervision requirements; documentation of technical quality review; Technologist billing: the sleep technologist's services are covered by the facility's TC billing — technologists do not bill separately for attending the study; PSG interpretation documentation: the interpreting physician must sign the final report; the report must include all required elements (total sleep time, AHI, oxygen saturation, sleep stages, arousal index, clinical interpretation); the signed report is the documentation that supports the professional component billing (Modifier 26) claim; an auto-generated report that has not been reviewed and signed by the physician does not support the professional component billing.
Sleep Medicine Revenue Cycle Management That Maximizes Testing and DME Reimbursement
Valiant Lifecare's sleep medicine billing specialists manage PSG and HSAT code selection with appropriate TC/PC split billing, PAP compliance documentation coordination, MSLT and MWT coding, prior authorization for in-lab sleep studies, DME order documentation, and the full spectrum of sleep medicine denial prevention and appeals.
Optimize Your Sleep Medicine Revenue Cycle